Tangier disease: still more questions than answers - PubMed (original) (raw)
Review
Tangier disease: still more questions than answers
J-R Nofer et al. Cell Mol Life Sci. 2005 Oct.
Abstract
High-density lipoproteins (HDLs) play a central role in transporting cholesterol from peripheral tissues to the liver for elimination from the body. Impairment of HDL-mediated cholesterol transport favors cholesterol deposition in the arterial wall and promotes development of arteriosclerosis. Tangier disease is a severe HDL deficiency syndrome characterized by the accumulation of cholesterol in tissue macrophages and prevalent atherosclerosis. A three-decade search for a culprit in Tangier disease led to the identification of mutations in a cell membrane protein called ABCA1, which mediates the secretion of excess cholesterol from cells into the HDL metabolic pathway. Because of its ability to deplete cells of cholesterol and to raise plasma HDL levels, ABCA1 has become a promising therapeutic target for preventing cardiovascular disease.
Similar articles
- Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1.
Oram JF. Oram JF. Trends Mol Med. 2002 Apr;8(4):168-73. doi: 10.1016/s1471-4914(02)02289-x. Trends Mol Med. 2002. PMID: 11927274 Review. - Tangier disease and ABCA1.
Oram JF. Oram JF. Biochim Biophys Acta. 2000 Dec 15;1529(1-3):321-30. doi: 10.1016/s1388-1981(00)00157-8. Biochim Biophys Acta. 2000. PMID: 11111099 Review. - ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins.
Oram JF, Vaughan AM. Oram JF, et al. Curr Opin Lipidol. 2000 Jun;11(3):253-60. doi: 10.1097/00041433-200006000-00005. Curr Opin Lipidol. 2000. PMID: 10882340 Review. - ABCA1. The gatekeeper for eliminating excess tissue cholesterol.
Oram JF, Lawn RM. Oram JF, et al. J Lipid Res. 2001 Aug;42(8):1173-9. J Lipid Res. 2001. PMID: 11483617 Review. - Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants.
Quazi F, Molday RS. Quazi F, et al. J Biol Chem. 2013 Nov 29;288(48):34414-26. doi: 10.1074/jbc.M113.508812. Epub 2013 Oct 4. J Biol Chem. 2013. PMID: 24097981 Free PMC article.
Cited by
- Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction.
Vergeer M, Brunham LR, Koetsveld J, Kruit JK, Verchere CB, Kastelein JJ, Hayden MR, Stroes ES. Vergeer M, et al. Diabetes Care. 2010 Apr;33(4):869-74. doi: 10.2337/dc09-1562. Epub 2010 Jan 12. Diabetes Care. 2010. PMID: 20067955 Free PMC article. - Asymmetry in the lipid affinity of bihelical amphipathic peptides. A structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides.
Sethi AA, Stonik JA, Thomas F, Demosky SJ, Amar M, Neufeld E, Brewer HB, Davidson WS, D'Souza W, Sviridov D, Remaley AT. Sethi AA, et al. J Biol Chem. 2008 Nov 21;283(47):32273-82. doi: 10.1074/jbc.M804461200. Epub 2008 Sep 19. J Biol Chem. 2008. PMID: 18805791 Free PMC article. - "Who's on first": determining the roster for the key players in the reverse cholesterol transport pathway.
Remaley AT. Remaley AT. Atherosclerosis. 2011 Oct;218(2):287-9. doi: 10.1016/j.atherosclerosis.2011.06.037. Epub 2011 Jul 7. Atherosclerosis. 2011. PMID: 21798543 Free PMC article. No abstract available. - Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease.
Platt FM, Wassif C, Colaco A, Dardis A, Lloyd-Evans E, Bembi B, Porter FD. Platt FM, et al. Annu Rev Genomics Hum Genet. 2014;15:173-94. doi: 10.1146/annurev-genom-091212-153412. Annu Rev Genomics Hum Genet. 2014. PMID: 25184529 Free PMC article. - HDL and cholesterol: life after the divorce?
Vickers KC, Remaley AT. Vickers KC, et al. J Lipid Res. 2014 Jan;55(1):4-12. doi: 10.1194/jlr.R035964. Epub 2013 Mar 19. J Lipid Res. 2014. PMID: 23515282 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical